Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials Momentum

Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	Volume	Vol 1d %	SMA 10	SMA 20	SMA 50	SMA 100	SMA 200	RSI	Stochastic %K	Stochastic %D	StochRSI %K	StochRSI %D	MACD	MACD Signal	MACD Histogram	Beta
LXRX	LEXICON PHARMACEUTICALS INC	$0.73	4,076,918	-28.53%	0.66	0.58	0.50	0.64	1.12	67.33	73.20	71.12	82.56	81.97	0.06	0.05	0.02	1.37
IKT	INHIBIKASE THERAPEUTICS INC	$2.24	49,845	-62.12%	2.12	2.00	2.20	2.53	2.14	55.08	93.00	92.38	92.44	91.04	0.02	-0.03	0.05	0.87
ITOS	ITEOS THERAPEUTICS INC	$7.50	1,154,456	41.35%	7.12	6.32	6.68	7.17	9.76	61.84	86.46	83.60	76.45	77.04	0.25	0.09	0.16	1.05
ZLAB	ZAI LAB LTD	$31.15	474,034	-48.47%	31.76	30.69	33.55	30.18	26.73	47.35	65.04	71.91	67.29	77.86	-0.33	-0.56	0.22	1.20
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$5.36	52,561	39.64%	6.04	7.63	N/A	N/A	N/A	30.69	10.93	10.61	N/A	N/A	N/A	N/A	N/A	-1.98
VALN	VALNEVA SE	$6.38	2,012	-86.49%	6.70	6.61	6.90	5.96	6.10	44.49	30.45	40.29	5.28	26.63	-0.07	-0.03	-0.04	1.03
MDGL	MADRIGAL PHARMACEUTICALS INC	$327.70	833,796	100.14%	318.86	316.65	327.35	322.67	291.29	52.55	82.75	88.47	83.49	92.57	0.86	-2.46	3.32	0.78
PVLA	PALVELLA THERAPEUTICS INC	$24.09	55,488	-62.62%	25.05	23.79	24.28	19.28	17.72	48.88	50.86	56.24	42.12	50.62	0.12	0.21	-0.09	0.86
ARDX	ARDELYX INC	$5.47	6,427,684	63.69%	5.11	4.81	5.07	5.19	5.51	63.10	92.43	94.75	98.44	99.48	0.11	-0.01	0.12	1.21
AXSM	AXSOME THERAPEUTICS INC	$112.24	423,932	-40.20%	106.89	103.94	115.76	107.87	98.94	56.89	94.97	93.86	99.86	99.95	-1.01	-2.76	1.74	0.94
ARTV	ARTIVA BIOTHERAPEUTICS INC	$2.37	86,133	-20.19%	2.41	2.34	3.52	5.73	N/A	40.45	80.65	70.06	87.91	92.66	-0.32	-0.43	0.11	1.14
XCUR	EXICURE INC	$9.97	9,156	-19.18%	10.66	11.32	11.48	12.44	8.44	40.66	49.56	54.31	73.39	80.13	-0.44	-0.32	-0.12	0.91
MDCX	MEDICUS PHARMA LTD	$4.32	31,155	191.69%	4.03	3.85	3.61	3.21	N/A	62.04	58.23	55.02	92.57	88.74	0.19	0.15	0.03	0.56
ATYR	ATYR PHARMA INC	$3.34	1,042,430	39.80%	3.36	3.11	3.38	3.47	2.90	52.43	74.36	74.05	72.33	73.60	0.04	-0.01	0.05	0.85
TCRX	TSCAN THERAPEUTICS INC	$1.55	159,990	-44.89%	1.58	1.40	1.62	2.19	3.87	51.90	76.64	79.52	70.10	74.52	0.02	-0.03	0.04	0.67
MDWD	MEDIWOUND LTD	$17.25	32,421	-4.80%	17.82	16.82	16.96	17.55	17.64	50.79	76.74	85.21	59.58	81.73	0.32	0.20	0.12	0.74
ALEC	ALECTOR INC	$1.22	1,606,690	4.10%	1.12	1.06	1.30	1.56	3.28	54.39	84.42	79.15	95.95	93.95	-0.02	-0.06	0.04	1.47
LENZ	LENZ THERAPEUTICS INC	$28.88	247,573	-13.62%	26.75	23.94	24.08	25.83	25.95	62.98	91.36	88.29	85.30	83.35	1.20	0.59	0.61	1.31
SMMT	SUMMIT THERAPEUTICS INC	$24.67	3,521,482	-19.51%	26.71	23.64	21.26	20.44	18.86	51.97	32.41	35.62	7.78	16.46	1.46	1.71	-0.25	0.58
SEER	SEER INC	$2.04	212,169	-12.69%	2.00	1.96	1.96	2.16	2.04	56.13	47.86	48.75	27.77	25.73	0.02	0.01	0.01	1.84
MREO	MEREO BIOPHARMA GROUP PLC	$2.60	774,734	-3.90%	2.51	2.23	2.38	2.84	3.49	60.20	91.93	92.30	90.78	92.04	0.07	0.01	0.07	1.00
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$4.76	2,178	-93.42%	4.71	N/A	N/A	N/A	N/A	78.40	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-1.38
XNCR	XENCOR INC	$10.86	555,677	-30.83%	10.62	9.66	11.78	16.45	18.44	51.69	67.86	66.50	94.17	93.53	-0.21	-0.55	0.34	1.07
ORMP	ORAMED PHARMACEUTICALS INC	$2.27	20,211	-74.51%	2.28	2.21	2.26	2.31	2.35	51.22	85.54	88.54	80.73	83.55	0.02	0.00	0.01	1.07
ZBIO	ZENAS BIOPHARMA INC	$11.56	193,471	29.96%	10.27	9.02	8.27	8.38	N/A	72.12	97.35	94.02	99.60	99.08	0.86	0.57	0.29	1.23
BPMC	BLUEPRINT MEDICINES CORP	$99.25	1,715,676	55.04%	87.76	84.75	88.08	93.84	94.00	72.02	95.79	95.69	99.86	99.86	0.94	-0.78	1.72	1.15
TRDA	ENTRADA THERAPEUTICS INC	$9.05	102,562	-19.58%	8.73	8.33	9.83	12.65	14.72	51.00	82.93	81.80	97.81	97.65	-0.21	-0.44	0.23	1.04
BDTX	BLACK DIAMOND THERAPEUTICS INC	$1.70	669,204	-9.91%	1.59	1.49	1.68	2.01	3.20	58.48	93.42	92.16	98.59	97.36	-0.00	-0.05	0.05	1.42
RYTM	RHYTHM PHARMACEUTICALS INC	$63.80	619,990	54.11%	62.66	59.86	55.61	56.42	53.90	61.39	91.74	95.89	84.63	94.77	2.69	2.31	0.37	1.22
ABVC	ABVC BIOPHARMA INC	$1.03	124,222	-34.96%	0.94	0.93	0.81	0.67	0.66	58.20	83.08	75.11	88.03	82.52	0.06	0.05	0.01	0.45
ZYME	ZYMEWORKS INC	$12.88	409,671	-26.20%	12.44	11.54	12.24	13.20	12.86	59.93	94.10	94.45	94.66	96.59	0.23	-0.02	0.25	0.93
RARE	ULTRAGENYX PHARMACEUTICAL INC	$38.97	635,108	-15.03%	37.40	35.56	37.97	40.93	46.44	60.65	94.57	93.58	99.58	99.24	0.34	-0.31	0.65	1.09
SION	SIONNA THERAPEUTICS INC	$12.90	245,615	188.96%	12.11	10.71	13.13	N/A	N/A	52.55	82.28	79.37	89.21	85.83	-0.13	-0.62	0.49	0.72
RLAY	RELAY THERAPEUTICS INC	$3.29	1,852,557	-54.53%	3.09	2.70	3.06	3.74	5.25	59.88	86.99	90.68	90.95	92.54	0.09	-0.02	0.11	1.70
PRME	PRIME MEDICINE INC	$1.74	802,706	-32.79%	1.63	1.47	1.89	2.39	3.26	53.43	76.72	74.00	87.22	84.95	-0.04	-0.10	0.07	1.90
VTVT	VTV THERAPEUTICS INC	$20.51	4,798	-5.77%	20.90	19.30	18.30	16.94	16.15	54.97	51.19	68.81	10.31	40.09	0.99	0.90	0.09	0.82
FTRE	FORTREA HOLDINGS INC	$6.08	2,046,127	21.21%	5.78	5.76	8.66	13.35	17.43	41.65	87.81	82.36	94.49	97.64	-0.72	-1.05	0.33	1.55
PHIO	PHIO PHARMACEUTICALS CORP	$1.89	145,651	-28.96%	2.23	1.94	1.60	1.95	2.50	49.80	28.54	38.22	0.00	16.99	0.14	0.19	-0.05	1.05
NNNN	ANBIO BIOTECHNOLOGY	$6.29	18,347	15.81%	6.55	6.58	6.76	N/A	N/A	41.27	27.13	32.32	29.83	37.52	-0.12	-0.07	-0.05	-0.04
AARD	AARDVARK THERAPEUTICS INC	$11.33	171,660	150.02%	9.04	8.38	9.77	N/A	N/A	62.02	96.06	95.33	96.35	95.52	0.25	-0.36	0.61	1.21
NEUP	NEUPHORIA THERAPEUTICS INC	$5.00	19,877	191.32%	5.14	5.08	5.18	4.60	5.22	46.12	55.53	68.50	34.48	58.85	-0.02	-0.01	-0.01	0.75
OABI	OMNIAB INC	$1.77	1,255,656	-79.85%	1.80	1.88	2.58	3.06	3.64	34.04	30.31	26.86	82.64	85.07	-0.22	-0.25	0.04	0.51
ASMB	ASSEMBLY BIOSCIENCES INC	$11.44	16,944	-0.81%	10.68	9.90	10.76	12.79	14.34	62.93	93.24	94.17	96.59	98.29	0.20	-0.09	0.29	0.91
TSHA	TAYSHA GENE THERAPIES INC	$2.41	6,673,179	547.75%	1.78	1.50	1.60	1.70	1.92	77.45	92.27	86.18	98.68	96.38	0.14	0.04	0.10	1.80
BBIO	BRIDGEBIO PHARMA INC	$38.40	4,510,299	-58.39%	35.81	34.32	34.23	32.77	29.25	66.30	88.46	90.48	99.58	97.48	1.00	0.51	0.49	1.47
RADX	RADIOPHARM THERANOSTICS LTD	$4.00	54,892	199.24%	4.08	4.18	5.01	5.24	N/A	39.38	17.61	19.51	21.54	27.11	-0.29	-0.31	0.01	0.46
ARVN	ARVINAS INC	$7.23	16,716,868	996.82%	8.90	7.90	10.48	14.80	20.36	36.56	74.09	88.11	73.15	90.70	-0.24	-0.52	0.28	1.32
NRSN	NEUROSENSE THERAPEUTICS LTD	$1.04	130,639	143.34%	1.00	1.00	1.05	1.08	1.06	53.68	45.88	42.92	38.14	29.61	-0.01	-0.02	0.00	0.51
GNLX	GENELUX CORP	$2.43	161,471	4.42%	2.81	2.59	3.29	3.26	2.86	38.85	52.61	67.78	50.12	67.82	-0.11	-0.16	0.05	1.27
IMTX	IMMATICS NV	$5.01	371,969	6.48%	4.62	4.28	4.48	5.37	7.97	62.06	96.91	95.64	100.00	98.43	0.11	-0.00	0.12	0.88
RAPP	RAPPORT THERAPEUTICS INC	$11.47	119,811	22.06%	11.05	10.12	10.12	13.44	17.73	58.12	68.54	66.97	79.45	77.82	0.33	0.11	0.22	1.28
IPSC	CENTURY THERAPEUTICS INC	$0.56	875,186	91.70%	0.53	0.49	0.56	0.77	1.22	56.33	81.88	75.41	90.13	80.99	-0.00	-0.02	0.01	1.25
FULC	FULCRUM THERAPEUTICS INC	$4.38	926,477	65.99%	3.65	3.21	3.20	3.68	4.66	76.84	88.47	84.88	97.89	93.46	0.24	0.11	0.12	1.23
CYTK	CYTOKINETICS INC	$42.92	1,569,116	-8.93%	40.23	39.10	42.30	44.96	49.76	58.88	92.36	93.00	100.00	100.00	0.03	-0.72	0.74	1.00
EVAX	EVAXION BIOTECH A	$1.56	9,165	-77.34%	1.50	1.45	1.75	2.94	8.17	47.84	56.71	64.58	74.48	81.51	-0.07	-0.12	0.05	0.53
PGEN	PRECIGEN INC	$1.55	706,588	-5.58%	1.52	1.43	1.62	1.40	1.23	52.22	76.81	77.88	74.58	77.85	-0.00	-0.03	0.03	1.72
OCUL	OCULAR THERAPEUTIX INC	$8.53	1,484,205	48.04%	7.95	7.39	7.37	7.82	8.52	63.14	93.62	92.36	100.00	98.52	0.28	0.14	0.14	1.48
IOVA	IOVANCE BIOTHERAPEUTICS INC	$3.33	10,760,330	52.03%	3.35	3.25	3.72	5.23	7.51	46.41	79.16	87.16	78.14	90.42	-0.06	-0.14	0.08	1.42
MGNX	MACROGENICS INC	$1.68	465,683	-46.72%	1.60	1.40	1.83	2.46	3.12	53.89	81.51	80.62	79.54	80.29	-0.01	-0.09	0.08	1.17
CGEN	COMPUGEN LTD	$1.52	129,193	-61.61%	1.47	1.39	1.57	1.76	1.76	52.72	82.99	81.80	83.52	86.18	-0.01	-0.05	0.03	1.69
ERAS	ERASCA INC	$1.49	753,228	1.74%	1.38	1.28	1.37	1.79	2.30	59.62	82.99	78.02	100.00	98.08	0.02	-0.02	0.04	1.44
YMAB	Y-MABS THERAPEUTICS INC	$4.11	203,869	20.14%	4.29	4.45	4.81	6.10	9.60	41.22	21.67	22.29	11.95	20.87	-0.21	-0.19	-0.01	1.48
QNCX	QUINCE THERAPEUTICS INC	$1.08	148,641	89.26%	1.09	1.09	1.28	1.50	1.25	41.86	55.63	62.60	63.50	70.80	-0.05	-0.07	0.02	0.71
RNAC	CARTESIAN THERAPEUTICS INC	$12.27	74,309	70.21%	11.60	11.29	14.48	16.88	17.20	48.56	73.08	73.70	94.69	94.85	-0.60	-0.95	0.35	1.31
MAIA	MAIA BIOTECHNOLOGY INC	$2.48	570,082	53.89%	2.03	1.77	1.72	1.87	2.33	74.21	90.72	80.92	95.16	84.01	0.17	0.09	0.09	0.49
SXTP	60 DEGREES PHARMACEUTICALS INC	$2.48	67,775	-29.62%	2.84	2.75	2.22	3.72	5.22	47.00	7.73	15.91	3.91	9.46	0.11	0.18	-0.07	-0.59
ITRM	ITERUM THERAPEUTICS PLC	$1.08	583,313	-13.06%	1.17	1.14	1.28	1.51	1.39	42.50	18.70	32.25	41.93	50.99	-0.04	-0.04	0.00	1.08
RZLT	REZOLUTE INC	$3.96	887,642	93.84%	3.61	3.10	3.41	4.14	4.51	65.38	77.49	75.89	85.86	85.95	0.18	0.03	0.15	0.70
AVXL	ANAVEX LIFE SCIENCES CORP	$9.31	743,278	16.23%	9.31	8.92	8.87	9.32	7.88	53.82	80.20	86.38	74.22	88.95	0.17	0.10	0.07	1.66
VRDN	VIRIDIAN THERAPEUTICS INC	$13.74	605,651	4.27%	13.46	12.80	14.27	16.53	18.07	52.03	72.34	73.24	90.00	88.44	-0.17	-0.38	0.22	0.60
DNLI	DENALI THERAPEUTICS INC	$16.06	1,137,685	-40.50%	15.20	13.83	15.09	18.55	22.29	59.48	91.41	95.10	92.80	97.60	0.43	-0.08	0.51	1.52
IMCR	IMMUNOCORE HOLDINGS PLC	$30.15	104,331	-17.99%	29.90	28.34	29.02	29.59	32.00	57.68	85.76	88.53	86.77	92.25	0.47	0.17	0.31	0.74
BDRX	BIODEXA PHARMACEUTICALS PLC	$1.41	34,109	109.89%	1.46	1.51	2.05	3.21	6.66	39.64	33.86	38.98	42.72	57.72	-0.16	-0.21	0.05	0.89
SLS	SELLAS LIFE SCIENCES GROUP INC	$1.62	2,464,222	38.16%	1.40	1.26	1.21	1.16	1.19	82.72	88.74	86.37	100.00	100.00	0.10	0.06	0.04	1.05
TARA	PROTARA THERAPEUTICS INC	$3.46	445,543	-20.35%	3.82	3.89	4.00	4.56	3.35	39.74	23.20	29.43	7.75	15.20	-0.15	-0.09	-0.06	1.04
PRLD	PRELUDE THERAPEUTICS INC	$0.92	82,666	-41.94%	0.89	0.79	0.76	0.92	2.08	59.85	85.71	85.69	79.04	80.03	0.05	0.03	0.02	1.42
VIVS	VIVOSIM LABS INC	$1.97	134,714	-44.85%	1.86	1.89	3.82	4.20	5.09	41.91	43.98	35.19	80.35	64.57	-0.41	-0.54	0.13	0.74
BLTE	BELITE BIO INC	$61.90	13,847	29.28%	59.19	58.38	61.49	60.64	58.78	54.53	91.19	91.46	94.36	95.30	-0.24	-0.90	0.66	0.16
FATE	FATE THERAPEUTICS INC	$1.24	1,077,118	-48.50%	1.26	1.09	1.04	1.32	2.37	56.72	59.36	61.00	41.82	46.31	0.08	0.06	0.02	1.65
ACTU	ACTUATE THERAPEUTICS INC	$9.50	39,674	56.86%	8.88	8.15	7.60	8.02	N/A	70.59	93.31	90.74	100.00	98.54	0.51	0.37	0.14	0.64
DBVT	DBV TECHNOLOGIES SA	$8.61	35,611	-24.83%	8.82	8.09	6.08	5.01	4.45	59.65	68.03	71.76	27.82	38.01	0.85	0.89	-0.03	0.58
ADCT	ADC THERAPEUTICS SA	$1.43	200,238	-2.37%	1.34	1.26	1.50	1.70	2.32	54.56	82.62	85.33	89.89	92.28	-0.02	-0.06	0.04	1.18
COYA	COYA THERAPEUTICS INC	$6.28	40,413	-18.76%	6.20	5.77	6.24	6.11	6.40	53.02	68.77	66.44	77.97	76.97	0.06	-0.05	0.11	0.94
INSM	INSMED INC	$72.64	1,792,907	20.09%	70.88	69.88	74.32	74.23	73.79	52.26	91.85	86.35	98.90	92.37	-0.74	-1.29	0.55	1.05
JAGX	JAGUAR HEALTH INC	$11.87	106,439	-52.81%	8.97	6.99	9.52	16.60	24.45	70.63	68.10	64.82	97.64	98.31	0.79	-0.29	1.08	1.24
SGMO	SANGAMO THERAPEUTICS INC	$0.74	2,514,867	-12.56%	0.75	0.72	0.83	1.19	1.20	47.12	51.13	57.61	50.97	55.36	-0.02	-0.03	0.01	1.45
ACIU	AC IMMUNE SA	$1.67	136,820	-35.28%	1.61	1.59	2.00	2.38	2.87	44.27	78.55	79.03	93.83	97.36	-0.08	-0.13	0.05	1.04
BCAX	BICARA THERAPEUTICS INC	$14.71	799,562	36.90%	14.31	12.51	13.06	14.05	N/A	59.63	78.27	78.98	71.29	75.73	0.65	0.33	0.32	1.36
RNAZ	TRANSCODE THERAPEUTICS INC	$0.56	129,390,309	7,042.48%	0.38	0.40	1.34	3.85	8.85	42.09	67.72	69.20	97.07	97.19	-0.28	-0.42	0.13	1.33
NAMS	NEWAMSTERDAM PHARMA CO NV	$20.03	676,428	-21.79%	17.72	16.82	19.79	21.46	19.86	62.39	93.89	93.36	100.00	100.00	-0.28	-0.86	0.58	0.38
PSTV	PLUS THERAPEUTICS INC	$0.65	1,390,195	36.06%	0.77	0.76	0.91	1.06	1.25	42.70	16.83	25.15	30.24	43.32	-0.06	-0.06	0.00	0.66
ACOG	ALPHA COGNITION INC	$5.98	76,674	-24.74%	4.97	4.71	5.24	5.51	N/A	65.76	85.37	76.85	100.00	99.16	0.08	-0.11	0.19	0.89
ALXO	ALX ONCOLOGY HOLDINGS INC	$0.52	269,454	-30.95%	0.55	0.54	0.75	1.14	1.78	38.17	30.38	32.46	61.49	60.54	-0.06	-0.07	0.01	1.25
QTTB	Q32 BIO INC	$1.56	205,050	-81.52%	1.81	1.78	1.97	3.48	21.82	39.14	21.46	30.70	5.23	22.78	-0.11	-0.10	-0.01	1.10
MCRB	SERES THERAPEUTICS INC	$9.50	43,184	-67.03%	8.98	10.14	12.84	14.88	16.62	42.81	37.84	37.84	70.15	69.72	-1.11	-1.28	0.17	1.32
TIL	INSTIL BIO INC	$12.61	63,142	-78.86%	15.05	15.10	17.53	19.82	24.67	40.57	9.93	6.36	9.45	10.80	-1.25	-0.94	-0.31	1.69
UNCY	UNICYCIVE THERAPEUTICS INC	$0.65	373,010	-58.09%	0.63	0.59	0.59	0.63	0.53	60.74	88.85	89.13	96.46	97.36	0.02	0.01	0.01	0.69
IMMP	IMMUTEP LTD	$1.67	39,517	22.80%	1.63	1.55	1.72	1.88	2.00	52.20	74.23	76.63	91.38	93.34	-0.01	-0.04	0.03	0.96
TECX	TECTONIC THERAPEUTIC INC	$19.66	155,426	41.55%	19.84	18.20	21.05	32.11	30.35	49.13	69.32	74.09	66.29	71.15	-0.17	-0.79	0.62	1.19
SAVA	CASSAVA SCIENCES INC	$1.62	723,190	14.18%	1.57	1.43	2.02	2.30	13.34	47.43	73.41	72.94	87.99	86.41	-0.10	-0.16	0.07	1.36

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 147.93% over the past year, overperforming other biotech stocks by 225 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 400% from Protalix Biotherapeutics's current stock price of $3.00.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.69% over the past year, overperforming other biotech stocks by 135 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.67% over the past year, overperforming other biotech stocks by 137 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.79% from Catalyst Pharmaceuticals's current stock price of $24.27.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.27%, which is 4 percentage points higher than the biotech industry average of 1.81%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.46%, which is 1 percentage points higher than the biotech industry average of 1.81%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is the same as the biotech industry average of 1.81%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 1.97% over the last week. Arvinas was the among the top losers in the biotechnology industry, dropping -24.84% yesterday.

Arvinas shares are trading lower. The company reported Q1 financial results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.78% in the past year. It has overperformed other stocks in the biotech industry by 39 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.35% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 6.23% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 102% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.13% of biotech stocks are rated B (Buy), 42.39% are rated C (Hold), 35.87% are rated D (Sell), and 15.87% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -169.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.